A U.S. federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

The Centre considers fixing retail prices for empagliflozin combinations as generic versions flood the market and lead to ...

The new polling from the firm of Tony Fabrizio, who served as Trump’s 2024 campaign pollster, found that Republicans trailed ...

Lupin launches generic Loteprednol Etabonate Ophthalmic Suspension in the US market, a bioequivalent to Lotemax, to treat eye ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...

During a Wednesday morning segment on CNN News Central, the data guru presented statistics demonstrating that Democrats are ...

A federal judge has denied Novartis (SIX:NOVN)’ request for a preliminary injunction that would have prevented MSN Pharmaceuticals from selling a generic version of heart medication Entresto.

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

The inaugural Avendus Wealth–Hurun India U30 List 2025 recognizes 79 outstanding Indian entrepreneurs under 30, highlighting ...